ProModel’s 3rd Annual Pharma Conference Highlights Client Success Stories
ProModel hosted the 3rd Annual Conference for Capacity and Productivity Improvement in the Pharmaceutical Industry on April 28th and 29th at the Hyatt Regency at Penn’s Landing in the heart of historic Philadelphia, PA. Decision makers within R&D and Manufacturing gathered together for two intense days of interactive workshops and informative presentations that showcased how simulation technology can drastically improve decision making capability. Afterword, the reception and dinner proved to be a great opportunity for attendees to network, exchange information, and share best practices specific to simulation technology being used across the Pharma Industry.
Those in attendance represented the following companies
From the very beginning, guests were able to get involved in 4 interactive workshops and model demonstrations, gaining hands-on experience using various ProModel tools. The Strategic Planning Workshop focused on the impact of different demands and capacities on long-term enterprise performance and how ProModel’s tools and methodology can empower Pharmaceutical companies to confidently and quickly assess this impact and make informed decisions. The Lean Six Sigma Workshop was available for those who were interested in learning how simulation can improve process performance and quality by reducing waste and process variation. The Optimizing Clinical Trial Recruitment Workshop allowed participants to discover how to utilize simulation technology to reduce risk and more accurately forecast clinical trial results. There was also a Streamline Supply Chains with Simulation Workshop for participants interested in using simulation to analyze and design supply chains in both the R&D and Post Launch environments.
The conference also provided a chance for decision makers to learn from other professionals who are currently using ProModel tools, and allowed for those clients to showcase how simulation technology has improved their operations. Speakers from various Pharma companies including Pfizer, Merck, and Johnson and Johnson gave presentations highlighting the importance of simulation and the efficiency of ProModel software. Robert Monty, a Business Analyst from Pfizer elaborated on how simulation technology in conjunction with a business sensitive methodology is enabling Pfizer management and clinical development teams to visualize, with a high degree of accuracy, future clinical trial recruitment performance. Another key speaker was Poplin Kroese from the Operational Excellence Group at Merck, who shared a high level view of Merck’s principles of portfolio management beyond the clinical spheres to the global development and commercialization of the products themselves. Joseph Fortunato, Associate Director of Project Management Analytics at Johnson and Johnson, then explained how ProModel simulation helped them forecast the future need for internal resources to support new development projects.
Overall, the 2009 ProModel Pharma Conference in Philadelphia was a success and a great learning opportunity for all involved. Many in attendance agreed that the conference was a highly interactive and informative, as well as useful towards building a business simulator community. ProModel would like to thank all those who attended and helped make the event possible. We look forward to continue providing practical simulation solutions for you and your organization.
To receive further information regarding the conference or to receive information concerning future ProModel conferences, please click here.